Nesina

Indicated to address glucose concentrations to manage type 2 diabetes and alleviate postprandial sugar spikes.

Dosage

Pack size

You will receive a quality generic equivalent of Nesina, depending on stock.

Prescription and consultation requirements for Nesina vary by destination and are determined by the fulfilment partner.

Nesina details

Condition: Type 2 Diabetes Mellitus
Alternative names: alogliptin
Therapeutic class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
Pharmacological class: Antidiabetic
Contraindications: diabetic ketoacidosis; history of severe hypersensitivity to alogliptin
Minor side effects: headache; stuffy nose; diarrhoea
Moderate side effects: upper respiratory tract infection; joint pain; nausea
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Originator: Takeda
Onset Time: 1–2 weeks
Duration: 24 hours
Storage instructions: Store below 25°C.
Drug interactions: Insulin; Diuretics
Age restrictions: Approved for adults.

Serious side effects

acute pancreatitis, requires immediate medical attention; severe anaphylaxis, requires immediate medical attention

Patient summary

indicated to address glucose concentrations to manage type 2 diabetes and alleviate postprandial sugar spikes.

Mechanism of action

Inhibits DPP-4, preventing degradation of active incretins to trigger insulin release and suppress glucagon output.

Pregnancy and breastfeeding

TGA Category B: Safety confirmed in animal studies. Breastfeeding: Consult a doctor.

Nesina is the originator brand name, made by Takeda. We use it to identify the medicine and are not affiliated with Takeda.

The fulfilment partner confirms whether the exact brand or an equivalent containing Alogliptin is offered.
The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
Check the final product details at checkout before confirming an order.